Product image of Metformina Combix (Metformin Hydrochloride) supplied by GNH India

Metformina Combix

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformina Combix (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformina Combix, is a biguanide presented as an oral tablet for oral use. It is employed to improve glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose production and increasing peripheral insulin sensitivity.

GNH India supplies Metformina Combix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams across global markets worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution.

Manufacturer / TM Owner

Laboratorios Combix, S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metformina Combix (metformin hydrochloride) is used to manage hyperglycemia in the type 2 diabetes pathway and related metabolic conditions.
  • Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.
  • Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes when combined with lifestyle measures.
  • Polycystic ovary syndrome: reduces insulin resistance and may improve ovulatory function in affected women.

How It Works

  • Metformin hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. The resulting decrease in hepatic glucose output, together with enhanced peripheral glucose uptake in muscle and adipose tissue through activation of AMP‑activated protein kinase, improves insulin sensitivity and lowers circulating blood glucose concentrations. It does not stimulate insulin secretion, which minimizes the risk of hypoglycemia when used as monotherapy.

Side Effects

Metformina Combix may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or flatulence
  • Diarrhea: loose stools, often transient
  • Metallic taste: altered taste perception
  • Decreased appetite: reduced food intake

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic disturbance
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis
  • Vitamin B12 deficiency: long‑term use may lead to hematologic abnormalities

Precautions & Warnings

  • When prescribing Metformina Combix, clinicians should consider several safety precautions to minimize risk.
  • Renal function assessment: evaluate eGFR before initiating and monitor periodically
  • Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment
  • Alcohol consumption: limit intake as it may increase acidosis risk
  • Pregnancy and lactation: use only if potential benefits outweigh risks
  • Drug interactions: review concomitant medications that affect renal clearance or increase lactic acidosis potential
  • Store at ambient temperature: keep in original container, protect from moisture and heat

Avoid Interactions

Metformina Combix can interact with other medicines, influencing its plasma concentration or the risk of adverse events.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure when combined with metformin
  • Cimetidine: can increase metformin plasma levels, raising lactic acidosis risk
  • Renally toxic drugs (e.g., aminoglycosides, NSAIDs): heighten risk of renal impairment

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of hypoglycemia
  • Thiazide diuretics: can attenuate glucose‑lowering effect
  • ACE inhibitors or ARBs: require renal function monitoring
  • Alcohol: excessive intake raises lactic acidosis risk

Frequently Asked Questions

Metformina Combix contains metformin hydrochloride and is indicated to improve glycemic control in adults with type 2 diabetes mellitus. It helps lower both fasting and post‑prandial blood glucose levels when used together with diet and exercise.

Metformin hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I and activates AMP‑activated protein kinase, which enhances peripheral glucose uptake. This dual action improves insulin sensitivity without stimulating insulin secretion.

The dose of Metformina Combix is individualized. A qualified prescriber determines the appropriate strength, frequency and titration schedule based on the patient’s renal function, glycemic targets and overall clinical condition.

Safety data for metformin during pregnancy and lactation are limited. It should be used only if the potential maternal benefit outweighs any possible risk to the fetus or infant, and always under medical supervision.

To place an order, submit an enquiry on the Metformina Combix product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformina Combix belongs to the biguanide class, which primarily lowers hepatic glucose output. Unlike sulfonylureas, it does not stimulate insulin release, resulting in a lower intrinsic risk of hypoglycemia. It is often used as first‑line therapy before adding agents such as DPP‑4 inhibitors or SGLT2 inhibitors when additional glucose lowering is needed.

Metformina Combix should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse events are lactic acidosis, which is rare but life‑threatening, and severe cutaneous reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if patients experience unexplained muscle pain, rapid breathing, abdominal discomfort, or skin blistering.

Metformina Combix is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, and in those with significant hepatic disease that could predispose to lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT